Cadrenal Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CVKD and other ETFs, options, and stocks.About CVKD
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
CEOQuang X. Pham
CEOQuang X. Pham
Employees4
Employees4
HeadquartersPonte Vedra Beach, Florida
HeadquartersPonte Vedra Beach, Florida
Founded2022
Founded2022
Employees4
Employees4
CVKD Key Statistics
Market cap16.50M
Market cap16.50M
Price-Earnings ratio-1.53
Price-Earnings ratio-1.53
Dividend yield—
Dividend yield—
Average volume82.48K
Average volume82.48K
High today$11.86
High today$11.86
Low today$7.45
Low today$7.45
Open price$9.47
Open price$9.47
Volume286.58K
Volume286.58K
52 Week high$22.90
52 Week high$22.90
52 Week low$7.45
52 Week low$7.45
Stock Snapshot
As of today, Cadrenal Therapeutics(CVKD) shares are valued at $7.95. The company's market cap stands at 16.5M, with a P/E ratio of -1.53.
As of 2025-12-16, Cadrenal Therapeutics(CVKD) stock has fluctuated between $7.45 and $11.86. The current price stands at $7.95, placing the stock +6.7% above today's low and -33.0% off the high.
Cadrenal Therapeutics(CVKD) shares are trading with a volume of 286.58K, against a daily average of 82.48K.
During the past year, Cadrenal Therapeutics(CVKD) stock moved between $7.45 at its lowest and $22.90 at its peak.
During the past year, Cadrenal Therapeutics(CVKD) stock moved between $7.45 at its lowest and $22.90 at its peak.
People also own
Based on the portfolios of people who own CVKD. This list is generated using Robinhood data, and it’s not a recommendation.